Articles Tagged With: multidrug-resistant
-
Incentivizing New Antibiotics to Kill Multidrug-Resistant Bugs
Bacteria have developed resistance to so many antibiotics that a familiar adage about these lifesaving drugs is “use ’em and lose ’em.” Ideas to break this cycle and create a market for new antibiotics include the proposed PASTEUR (Pioneering Antimicrobial Subscriptions To End Upsurging Resistance) Act of 2023, which has been reintroduced in Congress.
-
Navigating Antimicrobial Resistance
As more patients request antibiotics for managing many types of illnesses, it is no surprise that antimicrobial resistance is on the rise. According to the CDC, 2.8 million antimicrobial-resistant infections occur every year in the United States, with 35,000 deaths.
-
Infectious Disease Alert Updates
A Reservoir of Pharyngeal GC; Difficult-to-Treat vs. Standard Multidrug Resistance
-
CDC: Resistance Emerging to Last-Line Carbapenem Drugs
Carbapenems are a last-line antibiotic, one of the final weapons in the formulary against multidrug-resistant bacteria. But the ever-evolving bugs are starting to solve this drug class and have found an ingenious way to do it — genetic transfer of resistant properties to another Gram-negative bacterium.